Observational study on fluid therapy management in surgical adult patients

Maria J Colomina, Javier Ripollés-Melchor, Patricia Guilabert, José Luis Jover, Misericordia Basora, Concha Cassinello, Raquel Ferrandis, Juan V Llau, Judith Peñafiel, Maria J Colomina, Javier Ripollés-Melchor, Patricia Guilabert, José Luis Jover, Misericordia Basora, Concha Cassinello, Raquel Ferrandis, Juan V Llau, Judith Peñafiel

Abstract

Background: Perioperative fluid therapy management is changing due to the incorporation of different fluids, surgical techniques, and minimally invasive monitoring systems. The objective of this study was to explore fluid therapy management during the perioperative period in our country.

Methods: We designed the Fluid Day study as a cross-sectional, multicentre, observational study. The study was performed in 131 Spanish hospitals in February 2019. We included adult patients undergoing general anaesthesia for either elective or non-elective surgery. Demographic variables were recorded, as well as the type and total volume of fluid administered during the perioperative period and the monitorization used. To perform the analysis, patients were categorized by risk group.

Results: We recruited 7291 patients, 6314 of which were included in the analysis; 1541 (24.4%) patients underwent high-risk surgery, 1497 (23. 7%) were high risk patients, and 554 (8.7%) were high-risk patients and underwent high-risk surgery; 98% patients received crystalloids (80% balanced solutions); intraoperative colloids were used in 466 patients (7.51%). The hourly intraoperative volume in mL/kg/h and the median [Q1; Q3] administered volume (mL/kg) were, respectively, 6.67 [3.83; 8.17] ml/Kg/h and 13.9 [9.52;5.20] ml/Kg in low-risk patients undergoing low- or intermediate-risk surgery, 6 [4.04; 9.08] ml/Kg/h and 15.7 [10.4;24.5] ml/Kg in high- risk patients undergoing low or intermediate-risk surgery, 6.41 [4.36; 9.33] ml/Kg/h and 20.2 [13.3;32.4] ml/Kg in low-risk patients undergoing high-risk surgery, and 5.46 [3.83; 8.17] ml/Kg/h and 22.7[14.1;40.9] ml/Kg in high-risk patients undergoing high- risk surgery . We used advanced fluid monitoring strategies in 5% of patients in the intraoperative period and in 10% in the postoperative period.

Conclusions: The most widely used fluid was balanced crystalloids. Colloids were used in a small number of patients. Hourly surgery volume tended to be more restrictive in high-risk patients but confirms a high degree of variation in the perioperatively administered volume. Scarce monitorization was observed in fluid therapy management.

Trial registration: Clinical Trials: NCT03630744.

Keywords: Balanced crystalloids; Fluid therapy; Fluid therapy management; Hemodynamic monitoring; Practice guidelines; Surgical procedures.

Conflict of interest statement

MJC: Honoraria for meetings and honoraria from Baxtex - Spain for conferences and courses.

JR-M: Honoraria for conference and courses from Fresenius Kabi, Edwards Lifesciences and Dextera Medical.

CC: Honoraria for Baxter- Spain Conferences.

JLJ: Honoraria for Fresenius Kabi conferences.

PG: Honoraria for Baxter- Spain Conferences.

MB, RF, JVLL, JP: no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Flowchart
Fig. 2
Fig. 2
Fluid type (Prevalence and IC[95%]). HES: Hydroxyethyl starch
Fig. 3
Fig. 3
Density plot of ml/Kg of Crystalloids. * 15 patients with more than 100 ml/Kg in total were removed. In the densities graph we observe that, during the intraoperative period in most of the surgeries, the total ml/kg are concentrated between 0 and 20. In contrast, in the postoperative period we see that, the greater the patient and surgery risk, the more variability in the total ml/kg administered. This same variability is observed in the total administered volume in both the intra and postoperative periods

References

    1. Lechat JP, Van der Linden P. Fluid therapy in the intraoperative setting. Transfus Apher Sci. 2019;58(4):408–411. doi: 10.1016/j.transci.2019.06.016.
    1. Rehm M, Hulde N, Kammerer T, Meidert AS, Hofmann-Kiefer K. State of the art in fluid and volume therapy: a user-friendly staged concept. Anesthesist. 2019;68(Suppl 1):1–14. doi: 10.1007/s00101-017-0290-8.
    1. Malbrain MLNG, Langer T, Annane D, Gattinoni L, Elbers P, Hahn RG, De Laet I, Minini A, Wong A, Ince C, et al. Intravenous fluid therapy in the perioperative and critical care setting: executive summary of the International Fluid Academy (IFA) Ann Intensive Care. 2020;10(1):64. doi: 10.1186/s13613-020-00679-3.
    1. Malbrain MLNG, Jacobs R, Perner A. The search for the holy grail continues: the difficult journey towards the ideal fluid! J Crit Care. 2019;52:254–257. doi: 10.1016/j.jcrc.2019.04.015.
    1. Miller TE, Myles PS. Perioperative fluid therapy for major surgery. Anesthesiology. 2019;130(5):825–832. doi: 10.1097/ALN.0000000000002603.
    1. Messina A, Robba C, Calabrò L, Zambelli D, Iannuzzi F, Molinari E, Scarano S, Battaglini D, Baggiani M, De Mattei G, et al. Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery. Crit Care. 2021;25:43. doi: 10.1186/s13054-021-03464-1.
    1. Calvo-Vecino JM, Ripollés-Melchor J, Mythen MG, Casans-Francés R, Balik A, Artacho JP, Martínez-Hurtado E, Serrano Romero A, Fernández Pérez C, Asuero de Lis S, et al. Effect of goal-directed haemodynamic therapy on postoperative complications in low – moderate risk surgical patients: a multicenter randomized controlled trial (FEDORA trial) Br J Anaesth. 2018;120(4):734–744. doi: 10.1016/j.bja.2017.12.018.
    1. Della Rocca G, Vetrugno L, Tripi G, Deana C, Barbariol F, Pompeiet L. Liberal or restricted fluid administration: are we ready for a proposal of a restricted intraoperative approach? BMC Anesthesiol. 2014;14:62. doi: 10.1186/1471-2253-14-62.
    1. Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, Christophi C, Leslie K, McGuinness S, Parke R, et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018;378(24):2263–2274. doi: 10.1056/NEJMoa1801601.
    1. Thacker JKM, Mountford WK, Ernst FR, Krukas MR, Mythen MMG. Perioperative fluid utilization variability and association with outcomes: considerations for enhanced recovery efforts in sample US surgical populations. Ann Surg. 2016;263(3):502–510. doi: 10.1097/SLA.0000000000001402.
    1. Cordero MA, Moreno JM, Gomis P, Valero MA, Calleja MA. Pilot study of intravenous fluid therapy management in adult patients at a tertiary care hospital. Nutr Hosp. 2012;27:943–947.
    1. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27. doi: 10.1097/00005650-199801000-00004.
    1. Harrington D, D'Agostino RB, Gatsonis C, Hogan JW, Hunter DJ, Normand ST, Drazen JM, Hamel BM. New guidelines for statistical reporting in the journal. N Engl J Med. 2019;381(3):285–286. doi: 10.1056/NEJMe1906559.
    1. Team. RC. A language and environment for statistical computing. In: R Core Team (2018) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna. ; 2017.
    1. Hansen PB, Jensen BL, Skøtt O. Chloride regulates afferent arteriolar contraction in response to depolarization. Hypertension. 1998;32(6):1066–1070. doi: 10.1161/01.HYP.32.6.1066.
    1. Self WH, Semler MW, Wanderer JP, Wanderer JP, Wang L, Byrne DW, Collins SP, Slovis CM, Lindsell CJ, Ehrenfeld JM, et al. Balanced crystalloids versus saline in noncritically Ill adults. N Engl J Med. 2018;378(9):819–828. doi: 10.1056/NEJMoa1711586.
    1. Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, Stollings JL, Kumar AB, Hughes CG, Hernandez A, et al. Balanced crystalloids versus saline in critically Ill adults. N Engl J Med. 2018;378(9):829–839. doi: 10.1056/NEJMoa1711584.
    1. Pfortmueller CA, Fleischmann E. Acetate-buffered crystalloid fluids: current knowledge, a systematic review. J Crit Care. 2016;35:96–104. doi: 10.1016/j.jcrc.2016.05.006.
    1. Potura E, Lindner G, Biesenbach P, Funk GC, Reiterer C, Kabon B, Schwarz C, Druml W, Fleischmannet E. An acetate-buffered balanced crystalloid versus 0.9% saline in patients with end-stage renal disease undergoing cadaveric renal transplantation: a prospective randomized controlled trial. Anesth Analg. 2015;120(1):123–129. doi: 10.1213/ANE.0000000000000419.
    1. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to plasmalyte. Ann Surg. 2012;255(5):821–829. doi: 10.1097/SLA.0b013e31825074f5.
    1. Maheshwari K, Turan A, Makarova N, Ma C, Sakr Esa WA, Ruetzler K, Barsoum S, Kuhel AG, Ritchey MR, Higuera-Rueda C, et al. Saline versus lactated ringer's solution: The saline or Lactated Ringer's (SOLAR) trial. Anesthesiology. 2020;132(4):614–624. doi: 10.1097/ALN.0000000000003130.
    1. Ripollés-Melchor J, Chappell D, Espinosa A, Mhyten MG, Abad-Gurumeta A, Bergese SD, Casans-Francés R, Calvo-Vecino JM. Perioperative fluid therapy recommendations for major abdominal surgery. Via RICA recommendations revisited. Part I: Physiological background. Rev Esp Anestesiol Reanim. 2017;64(6):328–338. doi: 10.1016/j.redar.2017.02.008.
    1. Burdett E, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MPV, et al. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev. 2012;12.
    1. Saw MM, Chandler B, Ho KM. Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: a meta-analysis. Anaesth Intensive Care. 2012;40(1):17–32. doi: 10.1177/0310057X1204000104.
    1. Orbegozo Cortés D, Rayo Bonor A, Vincent JL. Isotonic crystalloid solutions: a structured review of the literature. Br J Anaesth. 2014;112(6):968–981. doi: 10.1093/bja/aeu047.
    1. Soni N. British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients (GIFTASUP): Cassandra’s view. Anaesthesia. 2009;64(3):235–238. doi: 10.1111/j.1365-2044.2009.05886_1.x.
    1. Clinical N, Center G. Intravenous fluid therapy in adults in hospital. Commissioned by the National Institute for Health and Care Excellence 2013. .
    1. Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens - a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238(5):641–648. doi: 10.1097/01.sla.0000094387.50865.23.
    1. Shin CH, Long DR, McLean D, Grabitz SD, Ladha K, Timm FP, Thevathasan T, Pieretti A, Ferrone C, Hoeft A, et al. Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study. Ann Surg. 2018;267(6):1084–1092. doi: 10.1097/SLA.0000000000002220.
    1. Cecconi M, Fasano N, Langiano N, Divella M, Costa MG, Rhodes A, Della RG. Goal-directed haemodynamic therapy during elective total hip arthroplasty under regional anesthesia. Crit Care. 2011;15(3):R132. doi: 10.1186/cc10246.
    1. Challand C, Struthers R, Sneyd JR, Erasmus PD, Mellor N, Hosie KB, Minto G. Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery. Br J Anaesth. 2012;108(1):53–62. doi: 10.1093/bja/aer273.
    1. Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MPW, Ahern A, Griggs K, Scott R, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery a randomized clinical trial and systematic review. JAMA. 2014;311(21):2181–2190. doi: 10.1001/jama.2014.5305.
    1. Kabon B, Sessler DI, Kurz A, Crystalloid–Colloid Study Team. Effect of Intraoperative Goal-directed Balanced Crystalloid versus Colloid Administration on Major Postoperative Morbidity: A Randomized Trial. Anesthesiology. 2019; 130(5): 728-744.
    1. Futier E, Garot M, Godet T, Biais M, Verzilli D, Ouattara A, Huet O, Lescot T, Lebuffe G, Dewitte A, et al. Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: The FLASH Randomized Clinical Trial. JAMA. 2020;323(3):225–236. doi: 10.1001/jama.2019.20833.
    1. Vincent JL, Pelosi P, Pearse R, Payen D, Perel A, Hoeft A, Romagnoli S, Ranieri VM, Ichai C, Forget P, et al. Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12. Crit Care. 2015;19(1):224. doi: 10.1186/s13054-015-0932-7.
    1. Huette P, Abou Arab O, Beyls C, Mahjoub Y. Fluid challenge: de la théorie à la pratique. Anesth Renim. 2019;5(6):492–501.
    1. Cannesson M, Ramsingh D, Rinehart J, Demirjian A, Vu T, Vakharia S, Imagawa D, Yu Z, Greenfield S, Kainet Z. Perioperative goal-directed therapy and postoperative outcomes in patients undergoing high-risk abdominal surgery: a historical-prospective, comparative effectiveness study. Crit Care. 2015;19(1):261. doi: 10.1186/s13054-015-0945-2.
    1. Sun Y, Chai F, Pan C, Romeiser JL, Gan TJ. Effect of perioperative goal-directed hemodynamic therapy on postoperative recovery following major abdominal surgery-a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2017;21(1):141. doi: 10.1186/s13054-017-1728-8.

Source: PubMed

3
Abonnere